Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
Conclusion: Few studies investigating cannabis and CDP analgesia assess abuse liability and cognitive endpoints, adverse effects that impact the long-term clinical utility of these drugs. Future studies should include these measures to optimize research and clinical care related to cannabis-based therapeutics.
PMID: 31687845 [PubMed - as supplied by publisher]
Source: The American Journal of Drug and Alcohol Abuse - Category: Addiction Authors: Cooper ZD, Abrams D Tags: Am J Drug Alcohol Abuse Source Type: research
More News: Addiction | Alcoholism | Brain | Chronic Pain | Neurology | Pain | Study | Substance Abuse